𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease

✍ Scribed by Dr. Thomas L. Perry; Voon Wee Yong; Catherine Bergeron; Shirley Hansen; Karen Jones

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
605 KB
Volume
21
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Assessment of glutathione-S-transferase
Assessment of glutathione-S-transferase and glutathione reductase in patients with squamous-cell carcinoma of buccal mucosa
✍ Rakesh M. Rawal; Devendra D. Patel; Beena P. Patel; Mintoo M. Patel; Manish K. W πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 116 KB πŸ‘ 2 views

Serum and tumor cytosolic levels of glutathione-S-transferase (GST) and glutathione-reductase (GR) activity were determined spectrophotometrically. The levels were correlated with clinicopathological criteria and a tobacco-associated protein band (T band) found in serum. The results showed significa

Glutathione-S-transferase genotypes and
Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease
✍ Gabriele Stocco; Stefano Martelossi; Arrigo Barabino; Giuliana Decorti; Fiora Ba πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 2 views

## Background: Adverse drug reactions to azathioprine, the prodrug of 6-mercaptopurine, occur in 15%-38% of patients and the majority are not explained by thiopurine-s-methyltransferase (tpmt) deficiency. azathioprine is known to induce glutathione depletion and consumption of glutathione is greate

Glutathione-S-transferase-1 and interleu
Glutathione-S-transferase-1 and interleukin-1Ξ² gene polymorphisms in Japanese patients with Parkinson's disease
✍ Masataka Nishimura; Sadako Kuno; Ryuji Kaji; Katsuhito Yasuno; Hideshi Kawakami πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 50 KB

## Abstract We studied genetic polymorphisms in the glutathione‐__S__‐transferase‐1 (GST‐1) gene region and the interleukin‐1Ξ² (IL‐1Ξ²) promoter region in patients with Parkinson's disease (PD, n = 361), as well as controls (n = 257). Although we have confirmed the previous results, in a larger samp